Hims Hers Health Inc (HIMS)
Solvency ratios
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — |
| Financial leverage ratio | 1.48 | 1.37 | 1.33 | 1.30 | 1.28 | 1.26 | 1.22 | 1.20 | 1.18 | 1.23 | 1.19 | 1.17 | 1.26 | 1.18 | 1.19 | 1.18 | — | — | — | — |
Hims Hers Health Inc has exhibited a consistently strong solvency position based on its debt-related ratios. The Debt-to-assets ratio has been consistently at 0.00% throughout the analyzed period, indicating that the company has no debt relative to its total assets.
The Debt-to-capital ratio and Debt-to-equity ratio have also shown a stable and healthy trend, with both ratios at 0.00% from March 31, 2021, onwards. This suggests that the company's capital structure is predominantly funded by equity, leading to lower financial risk and a strong financial position.
The Financial leverage ratio, which provides insight into the company's ability to meet its financial obligations through debt, has shown a slight increase over the years but has generally remained at a moderate level, ranging from 1.17 to 1.48. This indicates that while there has been a slight uptrend in leverage, the company has managed its debt levels within a reasonable range.
Overall, the solvency ratios of Hims Hers Health Inc suggest a stable and low-risk financial position with minimal reliance on debt financing, which is a positive indicator for investors and creditors alike.
Coverage ratios
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest coverage | — | 27.12 | 7.57 | -5.24 | -9.31 | -9.75 | -9.06 | -9.87 | -11.43 | -25.81 | -47.38 | -63.56 | — | — | — | — | -1,797.70 | -302.70 | -177.35 | -155.79 |
Based on the provided data, Hims Hers Health Inc's interest coverage ratio shows a fluctuating trend over the indicated periods. The interest coverage ratio is calculated by dividing earnings before interest and taxes (EBIT) by interest expense, and it provides insight into the company's ability to cover its interest expenses with its operating income.
From March 2020 to December 2023, the interest coverage ratio remains negative, indicating that the company's operating income is insufficient to cover its interest expenses. The substantial negative values during this period reflect a significant strain on the company's ability to meet its interest obligations from its operational earnings.
However, starting from June 2024, there is a notable improvement in the interest coverage ratio, turning positive and showing a gradual increase over subsequent periods. This positive trend suggests that the company's operating income has improved sufficiently to cover its interest costs, indicating a potentially stronger financial position.
Overall, the analysis of Hims Hers Health Inc's interest coverage ratio reveals a challenging period of inadequate coverage followed by a positive turnaround and improvement in the company's ability to meet its interest obligations with its operating income. It will be crucial to monitor future periods to assess the sustainability of this positive trend and its implications for the company's financial health.